Literature DB >> 17885418

Molecular mechanisms of plaque instability.

Prediman K Shah1.   

Abstract

PURPOSE OF REVIEW: Coronary artery thrombosis superimposed on a disrupted atherosclerotic plaque initiates abrupt arterial occlusion and is the proximate event responsible for 60-80% cases of acute coronary syndromes. This article provides a concise update on the evolving concepts in the pathophysiology of plaque rupture and thrombosis. RECENT
FINDINGS: Over the past several years, the critical role of plaque composition rather than plaque size or stenosis severity, in plaque rupture and thrombosis have been recognized. The necrotic lipid core and plaque inflammation appear to be key factors. Extracellular matrix loss in the fibrous cap, a prelude to rupture, is attributed to matrix degrading enzymes as well as to death of matrix synthesizing smooth muscle cells; inflammation appears to play a critical role in both these processes. Inflammatory cell derived tissue factor is a key contributor to plaque thrombogenicity. Inflammation has also been implicated in plaque neovascularity, intraplaque hemorrhage and plaque expansion. Recent observations have also highlighted the important modulatory role of immune system in atherosclerosis and plaque composition.
SUMMARY: Improved understanding of mechanisms causing plaque instability should provide novel insights into prevention of athero-thrombotic cardiovascular events.

Entities:  

Mesh:

Year:  2007        PMID: 17885418     DOI: 10.1097/MOL.0b013e3282efa326

Source DB:  PubMed          Journal:  Curr Opin Lipidol        ISSN: 0957-9672            Impact factor:   4.776


  35 in total

1.  Nonobstructive coronary artery disease and risk of myocardial infarction.

Authors:  Thomas M Maddox; Maggie A Stanislawski; Gary K Grunwald; Steven M Bradley; P Michael Ho; Thomas T Tsai; Manesh R Patel; Amneet Sandhu; Javier Valle; David J Magid; Benjamin Leon; Deepak L Bhatt; Stephan D Fihn; John S Rumsfeld
Journal:  JAMA       Date:  2014-11-05       Impact factor: 56.272

2.  Effects of emotional and physiological stress on plaque instability in apolipoprotein E knockout mice.

Authors:  Tao Zhang; Yongzhi Zhai; Yundai Chen; Zhenhong Zhou; Junjie Yang; Hongbin Liu
Journal:  J Physiol Biochem       Date:  2011-04-22       Impact factor: 4.158

3.  Proceedings from the scientific symposium: Sex differences in cardiovascular disease and implications for therapies.

Authors:  C Noel Bairey Merz; Saralyn Mark; Barbara D Boyan; Alice K Jacobs; Prediman K Shah; Leslee J Shaw; Doris Taylor; Eduardo Marbán
Journal:  J Womens Health (Larchmt)       Date:  2010-06       Impact factor: 2.681

4.  Overexpression of urokinase by plaque macrophages causes histological features of plaque rupture and increases vascular matrix metalloproteinase activity in aged apolipoprotein e-null mice.

Authors:  Jie Hong Hu; Liang Du; Talyn Chu; Goro Otsuka; Nagadhara Dronadula; Mia Jaffe; Sean E Gill; William C Parks; David A Dichek
Journal:  Circulation       Date:  2010-03-29       Impact factor: 29.690

Review 5.  Spectroscopy to improve identification of vulnerable plaques in cardiovascular disease.

Authors:  Janneke L M Bruggink; Robbert Meerwaldt; Gooitzen M van Dam; Joop D Lefrandt; Riemer H J A Slart; René A Tio; Andries J Smit; Clark J Zeebregts
Journal:  Int J Cardiovasc Imaging       Date:  2009-09-17       Impact factor: 2.357

6.  Inhibition of lipoprotein-associated phospholipase A2 reduces complex coronary atherosclerotic plaque development.

Authors:  Robert L Wilensky; Yi Shi; Emile R Mohler; Damir Hamamdzic; Mark E Burgert; Jun Li; Anthony Postle; Robert S Fenning; James G Bollinger; Bryan E Hoffman; Daniel J Pelchovitz; Jisheng Yang; Rosanna C Mirabile; Christine L Webb; LeFeng Zhang; Ping Zhang; Michael H Gelb; Max C Walker; Andrew Zalewski; Colin H Macphee
Journal:  Nat Med       Date:  2008-09-21       Impact factor: 53.440

7.  The SHAPE guideline: ahead of its time or just in time?

Authors:  Erling Falk; Prediman K Shah
Journal:  Curr Atheroscler Rep       Date:  2011-10       Impact factor: 5.113

8.  Dichotomy in Hedgehog signaling between human healthy vessel and atherosclerotic plaques.

Authors:  Karla C S Queiroz; Maarten F Bijlsma; René A Tio; Clark J Zeebregts; Marina Dunaeva; Carmen V Ferreira; Gwenny M Fuhler; Ernst J Kuipers; Maria M Alves; Farhad Rezaee; C Arnold Spek; Maikel P Peppelenbosch
Journal:  Mol Med       Date:  2012-09-25       Impact factor: 6.354

9.  CXCR4 blockade induces atherosclerosis by affecting neutrophil function.

Authors:  Ilze Bot; Isabelle T M N Daissormont; Alma Zernecke; Gijs H M van Puijvelde; Birgit Kramp; Saskia C A de Jager; Judith C Sluimer; Marco Manca; Veronica Hérias; Marijke M Westra; Martine Bot; Peter J van Santbrink; Theo J C van Berkel; Lishan Su; Mona Skjelland; Lars Gullestad; Johan Kuiper; Bente Halvorsen; Paul Aukrust; Rory R Koenen; Christian Weber; Erik A L Biessen
Journal:  J Mol Cell Cardiol       Date:  2014-05-08       Impact factor: 5.000

10.  Novel small leucine-rich repeat protein podocan is a negative regulator of migration and proliferation of smooth muscle cells, modulates neointima formation, and is expressed in human atheroma.

Authors:  Randolph Hutter; Li Huang; Walter S Speidl; Chiara Giannarelli; Paul Trubin; Gerhard Bauriedel; Mary E Klotman; Valentin Fuster; Juan J Badimon; Paul E Klotman
Journal:  Circulation       Date:  2013-09-16       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.